YuLife raises £95m in Series C funding

Takes total capital raised to £172m

Hemma Visavadia
clock • 1 min read
YuLife raises £95m in Series C funding

Life insurtech YuLife has raised a further $120m (£95m) through a Series C funding spearheaded by investor Dai-ichi Life.

The latest funding round takes the provider's total capital to $206m (£172m) since it was founded in 2016, having received support from investors such as Creandum, LocalGlobe, Target Global, Latitude, Anthemis, OurCrowd, Notion, MMC and Eurazeo. Last July, YuLife secured £50.6m through its Series B funding round to develop new products and expand its market growth. This year's funds will be used to broaden YuLife's reach into global markets and upscale its product range. Its current ...

To continue reading this article...

Join Cover

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around Covid-19, regulation, diversity and mental health.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Critical Illness

MAXIS Global Benefits Network partners with Further Group on CI offering

MAXIS Global Benefits Network partners with Further Group on CI offering

Further is seventh supplier to join network

Hemma Visavadia
clock 28 July 2022 • 1 min read
Case Study: Sandy's Story

Case Study: Sandy's Story

"It was almost surreal how it just happened."

Hemma Visavadia
clock 14 July 2022 • 1 min read
Cancer insurance fraudster jailed for six years over £2 million scam

Cancer insurance fraudster jailed for six years over £2 million scam

Received £1.2m from protection policy

John Brazier
clock 20 June 2022 • 3 min read